Suchen Sie nach Informationen zu Cellularity-Hauptquartier? Folgen Sie den Links unten, um alle Informationen zu finden, die Sie benötigen, und mehr.
https://craft.co/celularity
Celularity is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells (ASCs), targeting indications across cancer, immunologic, infectious, and degenerative diseases.
https://celularity.com/company/leadership/
Celularity Inc. 170 Park Ave Florham Park, NJ 07932 Company Pipeline Our Story Leadership Scientific Advisors Board of Directors Careers Science Placenta NK Cell Platform T Cell Platform Manufacturing Lifebank Biovance Investors Investor Relations Investor Newsroom Stock Information Corporate Governance SEC Filings Investor FAQs
https://craft.co/celularity
Celularity has offices in Warren, Madison and Carlton Open Map View Warren, NJ, US (HQ) 33 Technology Dr S Madison, NJ, US 170 Park Ave Carlton, AU Level 3/62 Lygon St Show all (3) Report incorrect company information Celularity Financials and Metrics Summary Metrics Celularity's latest funding round in February 2018 was reported to be $250 m.
https://celularity.com/celularity-reports-third-quarter-2021-financial-results-and-corporate-update/
Net income for the third quarter of 2021 was $49.9 million, or $0.47 per share (basic) and $0.40 per share (diluted). Year to Date Financial Results. Revenue for the nine months ended September 30, 2021, increased $5.4 million compared to the prior year period. The increase was due to an increase of $9.1 million in license, royalty and other ...
Cellarity has a blended team of experts in therapeutic development, genomics technology, systems biology, digital science and AI who are collaborating in an innovative way to usher in a new era of drug development. Our shared focus is to create breakthrough medicines that change the lives of patients in a wide range of diseases. Learn More
https://www.globenewswire.com/news-release/2021/07/16/2264260/0/en/Celularity-Closes-Merger-with-GX-Acquisition-Corp-and-Provides-Corporate-Update.html
celularity, inc. (nasdaq: celu) headquartered in florham park, n.j., is a clinical stage biotechnology company leading the next evolution in cellular …
https://stockanalysis.com/stocks/celu/
FLORHAM PARK, N.J., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a clinical-stage biotechnology company developing placental-derived allogeneic cell therapies, today ... 8 months ago - GlobeNewsWire Celularity Appoints Andrew L. …
https://finance.yahoo.com/quote/CELU
florham park, n.j., march 15, 2022 (globe newswire) -- celularity inc. (nasdaq: celu) (“celularity”), a clinical-stage biotechnology company developing placental-derived off-the-shelf allogeneic...
Wir hoffen, dass Sie über die obigen Links alle notwendigen Informationen zu Cellularity-Hauptquartier gefunden haben.
